机构地区:[1]蚌埠医学院第二附属医院泌尿外科,安徽蚌埠233000 [2]山西医科大学第一医院泌尿外科,山西太原030001 [3]山西医科大学第一临床医学院,山西太原030001
出 处:《泌尿外科杂志(电子版)》2019年第3期17-21,共5页Journal of Urology for Clinicians(Electronic Version)
基 金:蚌埠医学院自然科学基金重点项目(NO.BYKY1749ZD)资助
摘 要:目的探讨3D后腹腔镜保留肾单位手术(nephron sparing surgery,NSS)治疗T1b期肾癌的安全性及有效性。方法回顾性分析自2015年1月至2018年12月作者单位收治的53例行3D后腹腔镜保留肾单位手术的T1b期肾癌患者的临床资料。结果53例患者均顺利完成NSS,无中转开放手术。手术时间70~220分钟,平均(142.6±45.1)分钟。热缺血时间14~35分钟,平均(24.2±6.6)分钟。术中出血量50~300ml,平均(104.2±48.6)ml。所有患者术中均未输血。术后1天血肌酐56~141μmol/L,平均(85.1±21.3)μmol/L。术后住院4~11天,平均(5.9±1.8)天。3例患者因肿瘤贴近集合系统,术后出现尿漏,予以留置双J管,随访未出现尿漏。术后病理提示:透明细胞癌44例,乳头状癌3例,嫌色细胞癌6例。术后随访3~42个月,平均(27.3±21.5)个月。术后1个月血肌酐39~135μmol/L,平均(67.4±18.1)μmol/L;术后3个月血肌酐45~129μmol/L,平均(70.3±15.2)μmol/L;术后6个月血肌酐41~137μmol/L,平均(68.1±19.1)μmol/L。术后1天血肌酐较术前明显升高,差异有统计学意义(P<0.01)。术后1个月、3个月、6个月血肌酐较术后1天明显下降,差异有统计学意义(P<0.01)。术后1个月、3个月、6个月之间血肌酐值比较,差异无统计学意义(P>0.05)。53例患者术后随访未发现肿瘤局部复发及远处转移。结论3D后腹腔镜保留肾单位手术治疗T1b期肾癌,创伤小、恢复快、安全有效,最大限度切除肿瘤的同时,能很好的保留余肾的功能,兼具安全性及有效性。Objective To study the safety and efficacy of 3D retroperitoneal laparoscopic nephron-sparing surgery for the treatment of stage T1b renal cell carcinoma(RCC).Methods A retrospective study was conducted,based on the clinical data of 53 patients with stage T1b RCC treated with 3D retroperitoneoscopic laparoscopic nephron sparing surgery from January 2015 to December 2018.Results All the operations were accomplished successfully without conversion to open surgery.The operation time ranged from 70 to 220 minutes[mean(142.6±45.1)minutes].The warm ischemia time was from 14 to 35 minutes[mean(24.2±6.6)minutes].The volume of intraoperative bleeding ranged from 50 to 300ml[mean(104.2±48.6)ml].No patient received intraoperative blood transfusion.The level of serum creatinine ranged from 56 to 141μmol/L at 1 day after surgery[mean(85.1±21.3)μmol/L].The postoperative hospital stay was from 4 to 11 days[mean(5.9±1.8)days].Urinary leakage happened in 3 patients postoperatively,double J tube was indwered and no urinary leakage was found during follow-up.In the postoperative pathological findings,there were 44 cases of clear cell carcinoma,3 cases of papillary carcinoma and 6 cases of chromophobe carcinoma.The postoperative follow-up ranged from 3 to 42 months,with an average of(27.3±21.5)months.The level of serum creatinine was 39 to 135μmol/L at 1 month after surgery[mean(67.4±18.1)μmol/L].The level of serum creatinine was from 45 to 129μmol/L at 3 months after surgery[mean(70.3±15.2)μmol/L].The level of serum creatinine ranged from 41 to 137μmol/L at 6 months after surgery[mean(68.1±19.1)μmol/L].The level of serum creatinine at day 1 after surgery was significantly higher than that of the preoperative one(P<0.01).The level of serum creatinine at 1 month,3 months and 6 months after surgery was significantly lower than the serum creatinine at day 1 postopertively(P<0.01).There was no significant difference in serum creatinine between 1 month,3 months and 6 months after surgery(P>0.05).No tumo
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...